Skip to main content

Bluejay Diagnostics Inc (BJDX) Stock

Bluejay Diagnostics Inc Stock Details, Movements and Public Alerts

Stock Details

Bluejay Diagnostics Inc (BJDX), a prominent company in the healthcare sector within the medical devices industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $0.57. Over the past 52 weeks, it has ranged between $0.46 and $7.94. This places the current price at 7.2% of its 52-week high and 23.9% above its 52-week low. Recent trading volume was recorded at 280,946. The 14-day Relative Strength Index (RSI) stands at 28.50, suggesting oversold conditions. The stock is currently trading below its 50-day moving average of $0.83 by 31.33%. Similarly, it is below its 200-day moving average of $1.85 by 69.19%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: -0.09, Signal Line: -0.08). There is currently 1 active alert set for BJDX by users.

52-Week Range

$7.94 - $0.46

-92.82% from high · +23.91% from low

Avg Daily Volume

464,491

20-day average

100-day avg: 3,713,318

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

0.11

EV/EBITDA

-0.10

EPS (TTM)

-$3.58

Price to Sales

54.99

Beta

0.89

Less volatile than market

Q:How is BJDX valued relative to its earnings and growth?
Valuation data is not available for this stock.
Q:What is BJDX's risk profile compared to the market?
With a beta of 0.89, Bluejay Diagnostics Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 0.11 indicates the stock trades below its accounting value, which could signal value or distress.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-7,236,399

Return on Equity

-98.90%

Return on Assets

-51.10%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

Q:How profitable and efficient is BJDX's business model?
Profitability metrics are not available for this stock.
Q:What are BJDX's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$2.6M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

4.47M

Book Value/Share

$4.75

Asset Type

Common Stock

Q:What is BJDX's market capitalization and position?
Bluejay Diagnostics Inc has a market capitalization of $2.6M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 4.47M shares outstanding, the company's ownership is relatively concentrated. As a participant in the MEDICAL DEVICES industry, it competes with other firms in this sector.
Q:How does BJDX's price compare to its book value?
Bluejay Diagnostics Inc's book value per share is $4.75, while the current stock price is $0.57, resulting in a price-to-book (P/B) ratio of 0.12. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$256.00

44812.28% upside potential

Analyst Recommendations

No analyst ratings available

Q:How reliable are analyst predictions for BJDX?
0 analysts cover BJDX with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $256.00 implies 44812.3% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on BJDX?
Current analyst recommendations:The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Oct 25, 2026, 02:16 AM

Technical Indicators

RSI (14-day)

28.50

Oversold

50-Day Moving Average

$0.83

-31.33% below MA-50

200-Day Moving Average

$1.85

-69.19% below MA-200

MACD Line

-0.09

MACD Signal

-0.08

MACD Histogram

-0.01

Bearish

Q:What does BJDX's RSI value tell investors?
The RSI (Relative Strength Index) for BJDX is currently 28.50, indicating the stock is in oversold territory (below 30). This indicates heavy selling pressure that may have pushed the price too low too fast. Oversold readings can present buying opportunities, but stocks can remain oversold in strong downtrends. Look for RSI to rise above 30 as a potential recovery signal. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret BJDX's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.09 below the signal line at -0.08, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($0.83) is below the 200-day MA ($1.85), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Oct 31, 2026, 12:37 AM

Active Alerts

Alert Condition
Reaches new 52-week high
Threshold
N/A
Created
Jul 26, 2026, 11:34 AM

Stay Ahead of the Market with Bluejay Diagnostics Inc Alerts

Set up price alerts for Bluejay Diagnostics Inc and get notified instantly when the price hits your target. Never miss an important price movement again.